Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright began coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research report released on Monday, MarketBeat reports. The firm issued a buy rating and a $9.00 target price on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings […]
HC Wainwright assumed coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a report released on Monday, MarketBeat reports. The brokerage issued a buy rating and a $9.00 price target on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings at […]
First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer. JERUSALEM, April 03,... | April 3, 2023
First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable...
Alpha Tau Medical (NASDAQ:DRTS – Get Rating) is one of 229 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Alpha Tau Medical to related businesses based on the strength of its profitability, institutional ownership, valuation, analyst recommendations, risk, dividends and earnings. Analyst Ratings […]